Kyowa Kirin Co., Ltd. (TYO:4151)
Japan · Delayed Price · Currency is JPY 2,394.00
+32.00 (1.35%)
May 1, 2026, 3:30 PM JST
Kyowa Kirin Earnings Call Transcripts
Fiscal Year 2025
-
Revenue and profits declined year-over-year due to restructuring and special retirement costs, but key products like Crysvita and Poteligeo showed strong growth in North America and EMEA. R&D pipeline advanced with promising data for Ziftomenib and Rocatinlimab, and AI-driven strategies are boosting market penetration.